These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 27993854

  • 21. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).
    Pfaller MA, Mendes RE, Sader HS, Castanheira M, Flamm RK.
    J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053
    [Abstract] [Full Text] [Related]

  • 22. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
    Cesur S, Irmak H, Simşek H, Cöplü N, Kılıç H, Arslan U, Bayramoğlu G, Baysan BO, Gülay Z, Hoşoğlu S, Berktaş M, Gencer S, Demiröz AP, Esen B, Karabiber N, Aydın F, Yalçın AN.
    Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647
    [Abstract] [Full Text] [Related]

  • 23. In Vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model.
    Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR.
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036691
    [Abstract] [Full Text] [Related]

  • 24. Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016).
    Carvalhaes CG, Huband MD, Reinhart HH, Flamm RK, Sader HS.
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617092
    [Abstract] [Full Text] [Related]

  • 25. Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study.
    Xiao M, Huang JJ, Zhang G, Yang WH, Kong F, Kudinha T, Xu YC.
    BMC Microbiol; 2020 Nov 16; 20(1):350. PubMed ID: 33198626
    [Abstract] [Full Text] [Related]

  • 26. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
    Nichol KA, Adam HJ, Hussain Z, Mulvey MR, McCracken M, Mataseje LF, Thompson K, Kost S, Lagacé-Wiens PR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2011 Mar 16; 69(3):320-5. PubMed ID: 21353960
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Emergence of SCCmec type III with variable antimicrobial resistance profiles and spa types among methicillin-resistant Staphylococcus aureus isolated from healthcare- and community-acquired infections in the west of Iran.
    Mohammadi S, Sekawi Z, Monjezi A, Maleki MH, Soroush S, Sadeghifard N, Pakzad I, Azizi-Jalilian F, Emaneini M, Asadollahi K, Pourahmad F, Zarrilli R, Taherikalani M.
    Int J Infect Dis; 2014 Aug 16; 25():152-8. PubMed ID: 24909489
    [Abstract] [Full Text] [Related]

  • 31. Australian Group on Antimicrobial Resistance Hospital-onset Staphylococcus aureus Surveillance Programme annual report, 2011.
    Coombs GW, Nimmo GR, Pearson JC, Collignon PJ, Bell JM, McLaws ML, Christiansen KJ, Turnidge JD, Australian Group on Antimicrobial Resistance.
    Commun Dis Intell Q Rep; 2013 Sep 30; 37(3):E210-8. PubMed ID: 24890956
    [Abstract] [Full Text] [Related]

  • 32. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
    Sader HS, Farrell DJ, Flamm RK, Jones RN.
    Surg Infect (Larchmt); 2016 Aug 30; 17(4):443-7. PubMed ID: 26990170
    [Abstract] [Full Text] [Related]

  • 33. Treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM, Cadena J, Javeri H.
    Methods Mol Biol; 2014 Aug 30; 1085():259-309. PubMed ID: 24085702
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections.
    Hodille E, Delouere L, Bouveyron C, Meugnier H, Bes M, Tristan A, Laurent F, Vandenesch F, Lina G, Dumitrescu O.
    Med Mal Infect; 2017 Mar 30; 47(2):152-157. PubMed ID: 27856079
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
    Changchien CH, Chen SW, Chen YY, Chu C.
    BMC Infect Dis; 2016 Jun 10; 16():276. PubMed ID: 27287530
    [Abstract] [Full Text] [Related]

  • 38. Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010.
    Tsao SM, Wang WY, Ko WC, Huang CH, Lu CT, Chuang YC, Liu CY, Liao CH, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Chen YH, Lu PL, Thomas CY, Hsueh PR.
    Diagn Microbiol Infect Dis; 2014 Oct 10; 80(2):162-7. PubMed ID: 25053202
    [Abstract] [Full Text] [Related]

  • 39. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
    Zhanel GG, Esquivel J, Zelenitsky S, Lawrence CK, Adam HJ, Golden A, Hink R, Berry L, Schweizer F, Zhanel MA, Bay D, Lagacé-Wiens PRS, Walkty AJ, Lynch JP, Karlowsky JA.
    Drugs; 2020 Feb 10; 80(3):285-313. PubMed ID: 31970713
    [Abstract] [Full Text] [Related]

  • 40. In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013).
    Huband MD, Castanheira M, Farrell DJ, Flamm RK, Jones RN, Sader HS, Mendes RE.
    Int J Antimicrob Agents; 2016 Jun 10; 47(6):495-9. PubMed ID: 27211209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.